Atom Investors LP Krystal Biotech, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $542,767 - $651,360	5,002 New	5,002 $580,000
Q3 2020 Nov 13, 2020	SELL	$37.76 - $48.49 $1.1 Million - $1.41 Million	-29,117 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$37.03 - $60.0 $706,680 - $1.15 Million	-19,084 Reduced 39.59%	29,117 $1.21 Million
Q1 2020 May 15, 2020	BUY	$35.02 - $65.64 $1.69 Million - $3.16 Million	48,201 New	48,201 $2.08 Million

309

24.3M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.06B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.